• DarioHealth priced a registered direct offering of 3,454,559 common shares or equivalents at USD 6.8 per share.
• Gross proceeds expected at about USD 23.5 million; closing expected around July 23, 2026, subject to customary conditions.
• A board member bought 14,430 shares at USD 6.93 per share.
• Net proceeds earmarked for working capital, investments, acquisitions, general corporate purposes.
• A.G.P./Alliance Global Partners acting as sole placement agent.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DarioHealth Corp. published the original content used to generate this news brief on July 22, 2026, and is solely responsible for the information contained therein.